{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:42:17Z","timestamp":1790066537655,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Canadian Islet Research and Training Network","award":["NSERC-CREATE MSc award"],"award-info":[{"award-number":["NSERC-CREATE MSc award"]}]},{"DOI":"10.13039\/100008794","name":"Research Manitoba","doi-asserted-by":"publisher","award":["MSc studentship in health research"],"award-info":[{"award-number":["MSc studentship in health research"]}],"id":[{"id":"10.13039\/100008794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008794","name":"Research Manitoba","doi-asserted-by":"publisher","award":["PhD studentship in health research"],"award-info":[{"award-number":["PhD studentship in health research"]}],"id":[{"id":"10.13039\/100008794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010318","name":"University of Manitoba","doi-asserted-by":"publisher","award":["UMGF 2024-2025"],"award-info":[{"award-number":["UMGF 2024-2025"]}],"id":[{"id":"10.13039\/100010318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013528","name":"Diabetes Canada","doi-asserted-by":"publisher","award":["OG-3-22-5694-PT"],"award-info":[{"award-number":["OG-3-22-5694-PT"]}],"id":[{"id":"10.13039\/100013528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-479641"],"award-info":[{"award-number":["PJT-479641"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008252","name":"Health Sciences Centre Foundation","doi-asserted-by":"publisher","award":["Operating grant 2022"],"award-info":[{"award-number":["Operating grant 2022"]}],"id":[{"id":"10.13039\/100008252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008795","name":"Manitoba Medical Service Foundation","doi-asserted-by":"publisher","award":["2023 Allen Rouse Basic Science Career Development Award"],"award-info":[{"award-number":["2023 Allen Rouse Basic Science Career Development Award"]}],"id":[{"id":"10.13039\/100008795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24506-6","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:28:52Z","timestamp":1763555332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Circulating senescence-associated secretory phenotype factors across the stages of type 1 diabetes in a cross-sectional cohort"],"prefix":"10.1038","volume":"15","author":[{"given":"Camille","family":"Pr\u00e9fontaine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Pipella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Heidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Alcasid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"24506_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41577-023-00985-4","volume":"24","author":"KC Herold","year":"2024","unstructured":"Herold, K. C. et al. The immunology of type 1 diabetes. Nat. Rev. Immunol. 24, 435\u2013451 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"24506_CR2","doi-asserted-by":"crossref","unstructured":"Powers, A. C. Type 1 diabetes mellitus: much progress, many opportunities. J. Clin. Invest. 131, e142242 (2021).","DOI":"10.1172\/JCI142242"},{"key":"24506_CR3","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel, R. A. et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the endocrine Society, and the American diabetes association. Diabetes Care. 38, 1964\u20131974 (2015).","journal-title":"Diabetes Care"},{"key":"24506_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1902226","volume":"381","author":"KC Herold","year":"2019","unstructured":"Herold, K. C. et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl. J. Med. 381, 603\u2013613 (2019).","journal-title":"N Engl. J. Med."},{"key":"24506_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.abc8980","volume":"13","author":"EK Sims","year":"2021","unstructured":"Sims, E. K. et al. Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals. Sci. Transl Med. 13, 1\u201315 (2021).","journal-title":"Sci. Transl Med."},{"key":"24506_CR6","doi-asserted-by":"crossref","unstructured":"Nakayasu, E. S. et al. Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity. Cell Rep. Med. 4, 101093 (2023).","DOI":"10.1016\/j.xcrm.2023.101093"},{"key":"24506_CR7","doi-asserted-by":"publisher","first-page":"20798","DOI":"10.1038\/s41598-024-71717-4","volume":"14","author":"OG Poll\u00e9","year":"2024","unstructured":"Poll\u00e9, O. G. et al. Plasma proteomics in children with new-onset type 1 diabetes identifies new potential biomarkers of partial remission. Sci. Rep. 14, 20798 (2024).","journal-title":"Sci. Rep."},{"key":"24506_CR8","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.2337\/dbi21-0036","volume":"71","author":"R Mallone","year":"2022","unstructured":"Mallone, R., Halliez, C., Rui, J. & Herold, K. C. The \u03b2-Cell in type 1 diabetes pathogenesis: A victim of circumstances or an instigator of tragic events? Diabetes 71, 1603\u20131610 (2022).","journal-title":"Diabetes"},{"key":"24506_CR9","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00125-023-05970-z","volume":"66","author":"PJ Thompson","year":"2023","unstructured":"Thompson, P. J., Pipella, J., Rutter, G. A., Gaisano, H. Y. & Santamaria, P. Islet autoimmunity in human type 1 diabetes: initiation and progression from the perspective of the beta cell. Diabetologia 66, 1971\u20131982 (2023).","journal-title":"Diabetologia"},{"key":"24506_CR10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","volume":"24","author":"F Ovalle","year":"2018","unstructured":"Ovalle, F. et al. Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nat. Med. 24, 1108\u20131112 (2018).","journal-title":"Nat. Med."},{"key":"24506_CR11","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jama.2023.2064","volume":"329","author":"GP Forlenza","year":"2023","unstructured":"Forlenza, G. P. et al. Effect of verapamil on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: a randomized clinical trial. JAMA - J. Am. Med. Assoc. 329, 990\u2013999 (2023).","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"24506_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S2213-8587(21)00139-X","volume":"9","author":"SE Gitelman","year":"2021","unstructured":"Gitelman, S. E. et al. Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol. 9, 502\u2013514 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"24506_CR13","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa2306691","volume":"389","author":"M Waibel","year":"2023","unstructured":"Waibel, M. et al. Baricitinib and \u03b2-cell function in patients with new-onset type 1 diabetes. N Engl. J. Med. 389, 2140\u20132150 (2023).","journal-title":"N Engl. J. Med."},{"key":"24506_CR14","doi-asserted-by":"publisher","first-page":"1212716","DOI":"10.3389\/fendo.2023.1212716","volume":"14","author":"J Cha","year":"2023","unstructured":"Cha, J., Aguayo-Mazzucato, C. & Thompson, P. J. Pancreatic \u03b2-cell senescence in diabetes: mechanisms, markers and therapies. Front. Endocrinol. (Lausanne). 14, 1212716 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"24506_CR15","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.cmet.2019.01.021","volume":"29","author":"PJ Thompson","year":"2019","unstructured":"Thompson, P. J. et al. Targeted elimination of senescent beta cells prevents type 1 diabetes. Cell. Metab. 29, 1045\u20131060 (2019).","journal-title":"Cell. Metab."},{"key":"24506_CR16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","volume":"25","author":"B Wang","year":"2024","unstructured":"Wang, B., Han, J., Elisseeff, J. H. & Demaria, M. The senescence-associated secretory phenotype and its physiological and pathological implications. Nat. Rev. Mol. Cell. Biol. 25, 958\u2013978 (2024).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"24506_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20194776","volume":"20","author":"PJ Thompson","year":"2019","unstructured":"Thompson, P. J., Shah, A., Apostolopolou, H. & Bhushan, A. BET proteins are required for transcriptional activation of the senescent islet cell secretome in type 1 diabetes. Int. J. Mol. Sci. 20, 1\u201313 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"24506_CR18","doi-asserted-by":"crossref","unstructured":"de Rubin, M. F. et al. PAHSAs reduce cellular senescence and protect pancreatic beta cells from metabolic stress through regulation of Mdm2\/p53. Proc. Natl. Acad. Sci. U. S. A. 119, e2206923119 (2022).","DOI":"10.1073\/pnas.2206923119"},{"key":"24506_CR19","doi-asserted-by":"publisher","first-page":"e3000599","DOI":"10.1371\/journal.pbio.3000599","volume":"18","author":"N Basisty","year":"2020","unstructured":"Basisty, N. et al. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 18, e3000599 (2020).","journal-title":"PLoS Biol."},{"key":"24506_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/rej.2022.0024","volume":"25","author":"JW Shin","year":"2022","unstructured":"Shin, J. W., Lee, E., Han, S., Choe, S. A. & Jeon, O. H. Plasma proteomic signature of cellular senescence and markers of biological aging among postmenopausal women. Rejuvenation Res. 25, 141\u2013148 (2022).","journal-title":"Rejuvenation Res."},{"key":"24506_CR21","doi-asserted-by":"crossref","unstructured":"Schafer, M. J. et al. The senescence-associated secretome as an indicator of age and medical risk. JCI Insight 5, e133668 (2020).","DOI":"10.1172\/jci.insight.133668"},{"key":"24506_CR22","doi-asserted-by":"publisher","first-page":"e033675","DOI":"10.1161\/JAHA.123.033675","volume":"13","author":"O Salman","year":"2024","unstructured":"Salman, O. et al. Prognostic significance and biologic associations of senescence-associated secretory phenotype biomarkers in heart failure. J. Am. Heart Assoc. 13, e033675 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"24506_CR23","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1007\/s11357-022-00685-2","volume":"44","author":"RA Fielding","year":"2022","unstructured":"Fielding, R. A. et al. Associations between biomarkers of cellular senescence and physical function in humans: observations from the lifestyle interventions for elders (LIFE) study. GeroScience 44, 2757\u20132770 (2022).","journal-title":"GeroScience"},{"key":"24506_CR24","doi-asserted-by":"crossref","unstructured":"Evans, D. S. et al. Proteomic analysis of the senescence-associated secretory phenotype: GDF-15, IGFBP-2, and cystatin-C are associated with multiple aging traits. J. Gerontol. Biol. Sci. Med. Sci. 79, glad265 (2024).","DOI":"10.1093\/gerona\/glad265"},{"key":"24506_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/acel.14104","volume":"23","author":"S Hamsanathan","year":"2024","unstructured":"Hamsanathan, S. et al. A molecular index for biological age identified from the metabolome and senescence-associated secretome in humans. Aging Cell. 23, 1\u201320 (2024).","journal-title":"Aging Cell."},{"key":"24506_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/acel.13415","volume":"20","author":"DA Englund","year":"2021","unstructured":"Englund, D. A. et al. Exercise reduces Circulating biomarkers of cellular senescence in humans. Aging Cell. 20, 1\u20135 (2021).","journal-title":"Aging Cell."},{"key":"24506_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","volume":"40","author":"JN Justice","year":"2019","unstructured":"Justice, J. N. et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine 40, 554\u2013563 (2019).","journal-title":"EBioMedicine"},{"key":"24506_CR28","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1038\/s41591-023-02543-w","volume":"29","author":"MM Gonzales","year":"2023","unstructured":"Gonzales, M. M. et al. Senolytic therapy in mild alzheimer\u2019s disease: a phase 1 feasibility trial. Nat. Med. 29, 2481\u20132488 (2023).","journal-title":"Nat. Med."},{"key":"24506_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","volume":"47","author":"LTJ Hickson","year":"2019","unstructured":"Hickson, L. T. J. et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine 47, 446\u2013456 (2019).","journal-title":"EBioMedicine"},{"key":"24506_CR30","doi-asserted-by":"publisher","first-page":"101524","DOI":"10.1016\/j.molmet.2022.101524","volume":"62","author":"G Brawerman","year":"2022","unstructured":"Brawerman, G., Pipella, J. & Thompson, P. J. DNA damage to \u03b2 cells in culture recapitulates features of senescent \u03b2 cells that accumulate in type 1 diabetes. Mol. Metab. 62, 101524 (2022).","journal-title":"Mol. Metab."},{"key":"24506_CR31","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.2337\/db20-0553","volume":"70","author":"A Midha","year":"2021","unstructured":"Midha, A. et al. Unique human and mouse \u03b2-cell senescence-associated secretory phenotype (SASP) reveal conserved signaling pathways and heterogeneous factors. Diabetes 70, 1098\u20131116 (2021).","journal-title":"Diabetes"},{"key":"24506_CR32","doi-asserted-by":"publisher","first-page":"E552","DOI":"10.1152\/ajpendo.00257.2024","volume":"327","author":"N Rampazzo Morelli","year":"2024","unstructured":"Rampazzo Morelli, N., Pr\u00e9fontaine, C., Pipella, J. & Thompson, P. J. Secreted GDF15 maintains transcriptional responses during DNA damage-mediated senescence in human beta cells. Am. J. Physiol. Endocrinol. Metab. 327, E552\u2013E562 (2024).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"24506_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/dc19-0880","volume":"43","author":"M Battaglia","year":"2020","unstructured":"Battaglia, M. et al. Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes. Diabetes Care. 43, 5\u201312 (2020).","journal-title":"Diabetes Care"},{"key":"24506_CR34","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00125-020-05115-6","volume":"63","author":"P Leete","year":"2020","unstructured":"Leete, P. et al. Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis. Diabetologia 63, 1258\u20131267 (2020).","journal-title":"Diabetologia"},{"key":"24506_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.202402354R","volume":"38","author":"K Girdhar","year":"2024","unstructured":"Girdhar, K. et al. Sex-specific cytokine, chemokine, and growth factor signatures in T1D patients and progressors. FASEB J. 38, 1\u201311 (2024).","journal-title":"FASEB J."},{"key":"24506_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-023-01524-9","volume":"9","author":"C Zhou","year":"2023","unstructured":"Zhou, C., Gao, Y., Ding, P., Wu, T. & Ji, G. The role of CXCL family members in different diseases. Cell. Death Discov. 9, 1\u201312 (2023).","journal-title":"Cell. Death Discov"},{"key":"24506_CR37","doi-asserted-by":"crossref","unstructured":"Mansfield, L. et al. Emerging insights in senescence: pathways from preclinical models to therapeutic innovations. Npj Aging 10, 53 (2024).","DOI":"10.1038\/s41514-024-00181-1"},{"key":"24506_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.20232136","volume":"221","author":"M Reimann","year":"2024","unstructured":"Reimann, M., Lee, S. & Schmitt, C. A. Cellular senescence: neither irreversible nor reversible. J. Exp. Med. 221, 1\u201319 (2024).","journal-title":"J. Exp. Med."},{"key":"24506_CR39","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2337\/dc24-er11a","volume":"47","author":"M Phillip","year":"2024","unstructured":"Phillip, M. et al. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care. 47, 1276\u20131298 (2024).","journal-title":"Diabetes Care"},{"key":"24506_CR40","doi-asserted-by":"publisher","first-page":"eabo3932","DOI":"10.1126\/sciadv.abo3932","volume":"8","author":"S Shrestha","year":"2022","unstructured":"Shrestha, S. et al. Aging compromises human islet beta cell function and identity by decreasing transcription factor activity and inducing ER stress. Sci. Adv. 8, eabo3932 (2022).","journal-title":"Sci. Adv."},{"key":"24506_CR41","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1093\/nar\/gkae313","volume":"52","author":"M Patra","year":"2024","unstructured":"Patra, M. et al. Senescence of human pancreatic beta cells enhances functional maturation through chromatin reorganization and promotes interferon responsiveness. Nucleic Acids Res. 52, 6298\u20136316\u00a0(2024).","journal-title":"Nucleic Acids Res."},{"key":"24506_CR42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nm.4054","volume":"22","author":"A Helman","year":"2016","unstructured":"Helman, A. et al. p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion. Nat. Med. 22, 412\u2013420 (2016).","journal-title":"Nat. Med."},{"key":"24506_CR43","first-page":"1","volume":"8","author":"X Jia","year":"2024","unstructured":"Jia, X. & Yu, L. Understanding islet autoantibodies in prediction of type 1 diabetes. J. Endocr. Soc. 8, 1\u20138 (2024).","journal-title":"J. Endocr. Soc."},{"key":"24506_CR44","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2337\/db20-0937","volume":"70","author":"MD Williams","year":"2021","unstructured":"Williams, M. D. et al. Genetic composition and autoantibody titers model the probability of detecting c-peptide following type 1 diabetes diagnosis. Diabetes 70, 932\u2013943 (2021).","journal-title":"Diabetes"},{"key":"24506_CR45","doi-asserted-by":"publisher","first-page":"932516","DOI":"10.3389\/fendo.2022.932516","volume":"13","author":"G Brawerman","year":"2022","unstructured":"Brawerman, G., Ntranos, V. & Thompson, P. J. Alpha cell dysfunction in type 1 diabetes is independent of a senescence program. Front. Endocrinol. (Lausanne). 13, 932516 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"24506_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/pedi.12286","volume":"16","author":"M Campbell-Thompson","year":"2015","unstructured":"Campbell-Thompson, M. Organ donor specimens: what can they tell Us about type 1 diabetes? Pediatr. Diabetes. 16, 320\u2013330 (2015).","journal-title":"Pediatr. Diabetes"},{"key":"24506_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cmet.2019.05.006","volume":"30","author":"C Aguayo-Mazzucato","year":"2019","unstructured":"Aguayo-Mazzucato, C. et al. Acceleration of \u03b2 cell aging determines diabetes and Senolysis improves disease outcomes. Cell. Metab. 30, 129\u2013142e4 (2019).","journal-title":"Cell. Metab."},{"key":"24506_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/acel.12950","volume":"18","author":"AK Palmer","year":"2019","unstructured":"Palmer, A. K. et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell. 18, 1\u201315 (2019).","journal-title":"Aging Cell."},{"key":"24506_CR49","doi-asserted-by":"crossref","unstructured":"Ogrodnik, M. et al. Cellular senescence drives age-dependent hepatic steatosis. Nat. Commun. 8, 15691 (2017).","DOI":"10.1038\/ncomms15691"},{"key":"24506_CR50","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867\u20132873 (2010).","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1038\/s41598-025-32511-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24506-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24506-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:01:33Z","timestamp":1768384893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24506-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24506"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24506-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-32511-y","URL":"https:\/\/doi.org\/10.1038\/s41598-025-32511-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40845"}}